Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.
about
Haploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectivesImproving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantationAssociation of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals.Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant RecipientsClinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complicationsExpanding role of cytomegalovirus as a human pathogen.Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
P2860
Q28080452-28E07F7A-D6A0-4147-83FD-CEFD57D8EEDEQ33597783-1F49D039-C68F-44BE-9A31-35E545C151F5Q35760200-C7911E2A-11D3-45A0-BF15-ABFAA2AD3A53Q35940701-28FA6CD1-F55B-466B-BCC8-900A66103063Q37091612-AFEC67D1-9666-4C60-8889-1109CE8693FFQ37227240-3F54BA59-FB1B-41E9-9CA4-7DF0B7926254Q38673038-906A3557-7B68-46D6-9A1A-088F8E9B735CQ41104283-9D2DE632-0FF3-441F-98AF-57CB4EDCE308Q45325509-8CABF94F-9C47-4EEA-B55A-E7D162EFF0D8
P2860
Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Immunological monitoring for g ...... ecipients: a pilot experience.
@en
Immunological monitoring for g ...... ecipients: a pilot experience.
@nl
type
label
Immunological monitoring for g ...... ecipients: a pilot experience.
@en
Immunological monitoring for g ...... ecipients: a pilot experience.
@nl
prefLabel
Immunological monitoring for g ...... ecipients: a pilot experience.
@en
Immunological monitoring for g ...... ecipients: a pilot experience.
@nl
P2093
P1433
P1476
Immunological monitoring for g ...... ecipients: a pilot experience.
@en
P2093
Beatriz Muñoz-Cobo
Carlos Solano
David Navarro
Dayana Bravo
Elisa Costa
Isabel Benet
María José Remigia
María Ángeles Clari
Paula Amat
Rafael de la Cámara
P304
P356
10.1097/TP.0B013E318224F263
P577
2011-08-01T00:00:00Z